Regulation of Bcl-xL:: a little bit of this and a little bit of STAT

被引:208
作者
Grad, JM [1 ]
Zeng, XR [1 ]
Boise, LH [1 ]
机构
[1] Univ Miami, Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA
关键词
D O I
10.1097/00001622-200011000-00006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Bcl-2 family of proteins are key regulators of apoptosis. Bcl-x(L) is an anti-apoptotic protein with a high degree of homology to Bcl-2; however, the signals that regulate Bcl-x(L) and Bcl-2 appear to be different. Levels of Bcl-x(L), but not Bcl-2, are increased in response to various survival signals. Furthermore, an inverse correlation between the levels of Bcl-2 and Bcl-x(L) has been reported for a number of cancers. Although the precise molecules that control Bcl-x(L) activity are unclear, the STAT, Rel/NF-kappaB, and Ets transcription factor families have recently been reported to directly regulate the bcl-x gene. Activated Ras, integrin, vitronectin, and hepatocyte growth factor signaling cascades have also been linked to changes in Bcl-x(L) expression. Bcl-x(L) can also be affected by post-translational mechanisms. Here we review recent advances in identifying the signaling pathways and factors involved in regulation of the bcl-x gene. Curr Opin Oncol 2000, 12:543-549 (C) 2000 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:543 / 549
页数:7
相关论文
共 80 条
  • [1] Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial tells through inhibition of NF-κB
    Badrichani, AZ
    Stroka, DM
    Bilbao, G
    Curiel, DT
    Bach, FH
    Ferran, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (04) : 543 - 553
  • [2] Bairey O, 1999, CLIN CANCER RES, V5, P2860
  • [3] BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH
    BOISE, LH
    GONZALEZGARCIA, M
    POSTEMA, CE
    DING, LY
    LINDSTEN, T
    TURKA, LA
    MAO, XH
    NUNEZ, G
    THOMPSON, CB
    [J]. CELL, 1993, 74 (04) : 597 - 608
  • [4] Identification of target genes of oncogenic transcription factors
    Boyd, KE
    Farnham, PJ
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (01): : 9 - 28
  • [5] Stat3 as an oncogene
    Bromberg, JF
    Wrzeszczynska, MH
    Devgan, G
    Zhao, YX
    Pestell, RG
    Albanese, C
    Darnell, JE
    [J]. CELL, 1999, 98 (03) : 295 - 303
  • [6] Overexpression of BCL-2, BCL-X, and BAX in primary central nervous system lymphomas that occur in immunosuppressed patients
    Camilleri-Broët, S
    Camparo, P
    Mokhtari, K
    Xuan, KH
    Martin, A
    Arborio, M
    Hauw, JJ
    Raphaël, M
    [J]. MODERN PATHOLOGY, 2000, 13 (02) : 158 - 165
  • [7] Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
    Catlett-Falcone, R
    Landowski, TH
    Oshiro, MM
    Turkson, J
    Levitzki, A
    Savino, R
    Ciliberto, G
    Moscinski, L
    Fernández-Luna, JL
    Nuñez, G
    Dalton, WS
    Jove, R
    [J]. IMMUNITY, 1999, 10 (01) : 105 - 115
  • [8] Catlett-Falcone Robyn, 1999, Current Opinion in Oncology, V11, P490, DOI 10.1097/00001622-199911000-00010
  • [9] The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-xL
    Chen, CL
    Edelstein, LC
    Gélinas, C
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (08) : 2687 - 2695
  • [10] Involvement of 5′-flanking κB-like sites within bcl-x gene in silica-induced Bcl-x expression
    Chen, F
    Demers, LM
    Vallyathan, V
    Lu, YJ
    Castranova, V
    Shi, XL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (50) : 35591 - 35595